Tanaka, Hidekazu http://orcid.org/0000-0002-1642-7039
Article History
Received: 18 November 2020
Revised: 7 December 2020
Accepted: 13 December 2020
First Online: 18 January 2021
Compliance with ethical standards
:
: Hidekazu Tanaka has received a speaker honorarium from Boehringer Ingelheim GmbH, Sumitomo Dainippon Pharma, AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation, Taisho Pharma Co., Ltd., TOA EIYO LTD, Bayer Yakuhin, Ltd, ONO PHARMACEUTICAL CO., LTD., General Electric Company, Daiichi Sankyo Company, Limited, Novartis International AG, Teijin Limited, Merck & Co., Inc., Sekisui Medical Company, Limited, and Philips Medical Systems.